A British baby’s death this year after getting Novartis’s gene therapy Zolgensma was not caused by a toxic drug reaction, the Swiss drugmaker said, allaying concerns over the $2.1 million-per-patient treatment’s risks.
An independent expert panel to the U.S. Food and Drug Administration on Wednesday recommended approval of GlaxoSmithKline Plc’s over-the-counter nicotine oral spray that aims to help smokers quit their addiction.
For two men trained as scientists, the bosses of Britain’s major insulin providers have had to become experts in ferry schedules, trucking laws and warehouse capacity as they seek to guarantee the supply of life-saving drugs through a chaotic Brexit.
With Britain sourcing the vast majority of the insulin needed by its 1 million diabetics from overseas, its biggest providers have had to restructure their supply chains in case a chaotic Brexit disrupts the normal arteries of trade.
Sandeep qualified as a pharmacist in 2002 and holds a Doctorate in Pharmacy Practice. He has worked as a Senior Pharmacist (Formulary) for an NHS hospital Trust as well as a Chief Pharmacist for a drug and alcohol service provider. Sandeep has been involved in research for over 10 years and is experienced in using various research instruments to explore the views and opinions of managers, doctors, pharmacists, nurses, patients, customers and other key stakeholders. Sandeep has a particular passion for qualitative research and the powerful insights he has been able to generate. He set up Qualicis Research in 2013 with a view to bring together his enthusiasm for conducting research and his experience as a healthcare professional in both the public and private sector. Sandeep is a Certified Member of the Market Research Society (CMRS) and member of the British Healthcare Business Intelligence Association (BHBIA).